Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Zinc peptidase implicated in ACS pathogenesis

Aug. 31, 2012

Topical cream improves female sexual arousal disorder in phase III trial

Aug. 31, 2012

PAR1 receptor antagonist prevents heart failure-induced atrial remodeling

Aug. 31, 2012

Creabilis products show promise as topical analgesics

Aug. 31, 2012

New data presented on Xiaflex in Peyronie's disease

Aug. 30, 2012

Phase III lomitapide study reaches week 78

Aug. 30, 2012

Pfizer presents first-in-human data on new PDE2A inhibitor for schizophrenia

Aug. 30, 2012

Novel candidate drug for heart failure completes phase I trial

Aug. 30, 2012

Candidate analgesic releases pregabalin and nitric oxide

Aug. 30, 2012

Biomarker has prognostic value in patients with diabetes and coronary artery disease

Aug. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...